Trials / Recruiting
RecruitingNCT07507643
A Study of Methylprednisolone in People Having Liver Surgery
A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylprednisolone | single preoperative dose of methylprednisolone |
Timeline
- Start date
- 2026-03-27
- Primary completion
- 2029-03-27
- Completion
- 2029-03-27
- First posted
- 2026-04-02
- Last updated
- 2026-04-02
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07507643. Inclusion in this directory is not an endorsement.